Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis by organ systems

K Chakravarty1

  • 1Department of Rheumatology, Havering Hospital NHS Trust, Haroldwood Hospital, Romford, UK.

Bailliere'S Clinical Rheumatology
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Systemic vasculitides are increasingly recognized as common, complex, non-infectious diseases affecting multiple organs. Their management is challenging and impacts healthcare resources significantly.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review.

Acta neurologica Scandinavica·2016
Same author

High-dose statin therapy and risk of intracerebral hemorrhage: a meta-analysis.

Acta neurologica Scandinavica·2015
Same author

A case of systemic nocardiosis in systemic vasculitis and a review of the literature.

Singapore medical journal·2013
Same author

Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.

QJM : monthly journal of the Association of Physicians·2013
Same author

Antisense inhibition of S6 kinase 1 produces improved glucose tolerance and is well tolerated for 4 weeks of treatment in rats.

Pharmacology·2010
Same author

Role of colchicine in primary localised cutaneous amyloidosis.

Indian journal of dermatology, venereology and leprology·2010
Same journal

Regional soft tissue pains: alias myofascial pain?

Bailliere's clinical rheumatology·1999
Same journal

The knee

Bailliere's clinical rheumatology·1999
Same journal

The elbow, forearm, wrist and hand

Bailliere's clinical rheumatology·1999
Same journal

Shoulder disorders: a state-of-the-art review

Bailliere's clinical rheumatology·1999
Same journal

The neck

Bailliere's clinical rheumatology·1999
Same journal

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
See all related articles

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Immunology

Background:

  • Systemic vasculitides were previously considered rare but are now recognized as common, non-infectious systemic diseases.
  • These conditions frequently involve multiple organs and present diagnostic and management challenges.
  • Systemic vasculitis significantly impacts healthcare resources due to its complexity and multi-organ involvement.

Purpose of the Study:

  • To highlight the increasing recognition of systemic vasculitides.
  • To emphasize the multi-organ involvement and management difficulties associated with these diseases.
  • To discuss the factors influencing the clinical outcome of vasculitic illnesses.

Main Methods:

  • Review of current understanding of systemic vasculitides.

Related Experiment Videos

  • Analysis of clinical presentation and diagnostic challenges.
  • Discussion of prognostic factors and management implications.
  • Main Results:

    • Systemic vasculitides are not uncommon and require multidisciplinary care.
    • Multi-organ involvement is a hallmark of these conditions.
    • Clinical outcomes are influenced by etiology, vessel characteristics, disease severity, and complications.

    Conclusions:

    • Systemic vasculitides are significant non-infectious diseases with considerable impact.
    • Effective management requires understanding diverse etiological factors and disease characteristics.
    • Prognosis is multifactorial, necessitating comprehensive patient assessment and treatment strategies.